Cambridge Investment Research Advisors
AHCO icon

Cambridge Investment Research Advisors’s AdaptHealth AHCO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,115
Closed -$277K – 3084
2021
Q2 		$277K Buy
+10,115
New +$288K ﹤0.01% 2532

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Cambridge Investment Research Advisors's AHCO Position: Q3 2021 in Review

Cambridge Investment Research Advisors sold out of AdaptHealth (AHCO) in Q3 2021, closing a stake of 10,115 shares — an estimated $277K sold.

Cambridge Investment Research Advisors first reported a position in AHCO in Q2 2021 and held it in 1 quarter. The position peaked at $277K in Q2 2021. 142 funds tracked by Wall St. Rank hold AHCO as of Q3 2021.

  • Cambridge Investment Research Advisors reported no remaining AdaptHealth position as of Q3 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,115 AdaptHealth shares in Q3 2021, an estimated $277K.
  • Cambridge Investment Research Advisors first reported a position in AdaptHealth in Q2 2021 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's AdaptHealth position peaked at $277K in Q2 2021.
  • 142 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.